华兰生物：关于参股公司收到药品注册临床试验受理通知书的公告

Core Viewpoint - Hualan Biological announced that its subsidiary, Hualan Gene Engineering Co., Ltd., has received a clinical trial application acceptance notice for the domestic production of Pembrolizumab injection from the National Medical Products Administration [2] Group 1 - The acceptance notice has the registration number CXSL2501079 [2]